Pharmaceutical biotechnology products approved within the European Union

Author： Walsh G.  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.55, Iss.1, 2003-01, pp. : 3-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biotechnology and applied genomics for health: initiatives of the European Union

By Aguilar A.   Rainer B.   Galetescu L.   Donnelly F.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 329-337

Elsevier

Access to resources Recommend Favorite

Biopharmaceuticals approved in the EU 1995-1999: a European Union-United States comparison

By Reichert J.M.   Healy E.M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 51, Iss. 1, 2001-01 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Rabeprazole [`Pariet'] has been approved in a new indication in the European Union

By  

Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

EFPIA workshop: the 2001 review of European Union pharmaceutical legislation

By Donna E.   Elena M.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 3, 2001-06 ,pp. : 145-149

Adis International

Access to resources Recommend Favorite

An Overview of the European Union's New Medicines Legislation: Implications for the Pharmaceutical Industry

By Jackman Margaret   Woods Kent  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite